10x Science Secures $4.8

10x Science, a company developing frontier AI models for life sciences, has secured $4.8 million in funding to advance its platform for drug development. The investment will support the company's mission to redefine how scientists understand and engineer biology, starting with critical stages of drug discovery and development.

The company addresses a significant bottleneck in the pharmaceutical industry. While AI-powered drug discovery is rapidly generating new therapeutic candidates, the subsequent process of deeply characterizing these protein therapeutics remains a manual, time-consuming, and error-prone endeavor. This traditional approach struggles to keep pace with the speed of discovery, delaying promising candidates from advancing to clinical trials. 10x Science's AI-native platform automates protein characterization and quality assessment, providing drug developers with the confidence to advance viable candidates and identify unsuitable ones early.

This $4.8 million capital infusion will be deployed to accelerate the development and scaling of 10x Science's AI platform. The funds are earmarked for expanding the company's technological capabilities and operational capacity, enabling it to provide an end-to-end solution that dramatically speeds up and scales up the preparation of drug candidates for the clinic. This strategic investment underscores the growing recognition of AI's potential to transform the development stage of new medicines.

The team behind 10x Science brings substantial expertise to this challenge, comprising Stanford University researchers from a Nobel Laureate's lab with over 18 years of collective domain experience and a track record of scientific publications, alongside a 2x YC Founder. This blend of scientific rigor and entrepreneurial drive positions the company to lead innovation in AI for life sciences.

With this funding, 10x Science is poised to significantly accelerate its growth and impact, aiming to empower drug developers to bring life-changing therapies to patients more efficiently and effectively.